Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Payables (2020 - 2024)

Immuneering has reported Payables over the past 5 years, most recently at $1.9 million for Q3 2024.

  • Quarterly results put Payables at $1.9 million for Q3 2024, changed 0.09% from a year ago — trailing twelve months through Sep 2024 was $1.9 million (changed 0.09% YoY), and the annual figure for FY2023 was $2.1 million, down 33.06%.
  • Payables for Q3 2024 was $1.9 million at Immuneering, down from $2.6 million in the prior quarter.
  • Over the last five years, Payables for IMRX hit a ceiling of $3.2 million in Q4 2022 and a floor of $1.2 million in Q2 2022.
  • Median Payables over the past 5 years was $1.9 million (2024), compared with a mean of $2.1 million.
  • Biggest five-year swings in Payables: surged 126.24% in 2022 and later plummeted 33.06% in 2023.
  • Immuneering's Payables stood at $1.5 million in 2020, then decreased by 5.82% to $1.4 million in 2021, then surged by 126.24% to $3.2 million in 2022, then plummeted by 33.06% to $2.1 million in 2023, then decreased by 8.0% to $1.9 million in 2024.
  • The last three reported values for Payables were $1.9 million (Q3 2024), $2.6 million (Q2 2024), and $2.3 million (Q1 2024) per Business Quant data.